Panitch H - Search Results

1

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells.

Jiang H, Milo R, Swoveland P, Johnson KP, Panitch H, Dhib-Jalbut S. Jiang H, et al. Among authors: panitch h. J Neuroimmunol. 1995 Aug;61(1):17-25. doi: 10.1016/0165-5728(95)00072-a. J Neuroimmunol. 1995. PMID: 7560008

2

Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI response.

Graber JJ, Ford D, Zhan M, Francis G, Panitch H, Dhib-Jalbut S. Graber JJ, et al. Among authors: panitch h. J Neuroimmunol. 2007 Apr;185(1-2):168-74. doi: 10.1016/j.jneuroim.2007.01.011. Epub 2007 Feb 27. J Neuroimmunol. 2007. PMID: 17328965 Free PMC article. Clinical Trial.

3

Additive effects of copolymer-1 and interferon beta-1b on the immune response to myelin basic protein.

Milo R, Panitch H. Milo R, et al. Among authors: panitch h. J Neuroimmunol. 1995 Sep;61(2):185-93. doi: 10.1016/0165-5728(95)00085-g. J Neuroimmunol. 1995. PMID: 7593554

4

Effect of propranolol and IFN-beta on the induction of MHC class II expression and cytokine production by IFN-gamma IN THP-1 human monocytic cells.

Li Q, Milo R, Panitch H, Bever CT Jr. Li Q, et al. Among authors: panitch h. Immunopharmacol Immunotoxicol. 1998 Feb;20(1):39-61. doi: 10.3109/08923979809034808. Immunopharmacol Immunotoxicol. 1998. PMID: 9543699

5

Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma.

Li Q, Milo R, Panitch H, Swoveland P, Bever CT Jr. Li Q, et al. Among authors: panitch h. Eur J Pharmacol. 1998 Jan 26;342(2-3):303-10. doi: 10.1016/s0014-2999(97)01509-4. Eur J Pharmacol. 1998. PMID: 9548401

6

Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis.

Graber J, Zhan M, Ford D, Kursch F, Francis G, Bever C, Panitch H, Calabresi PA, Dhib-Jalbut S. Graber J, et al. Among authors: panitch h. J Neuroimmunol. 2005 Apr;161(1-2):169-76. doi: 10.1016/j.jneuroim.2004.11.017. Epub 2005 Jan 25. J Neuroimmunol. 2005. PMID: 15748956 Clinical Trial.

7

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration.

Khan OA, Xia Q, Bever CT Jr, Johnson KP, Panitch HS, Dhib-Jalbut SS. Khan OA, et al. Among authors: panitch hs. Neurology. 1996 Jun;46(6):1639-43. doi: 10.1212/wnl.46.6.1639. Neurology. 1996. PMID: 8649563 Clinical Trial.

8

Combination therapy in multiple sclerosis.

Milo R, Panitch H. Milo R, et al. Among authors: panitch h. J Neuroimmunol. 2011 Feb;231(1-2):23-31. doi: 10.1016/j.jneuroim.2010.10.021. Epub 2010 Dec 15. J Neuroimmunol. 2011. PMID: 21111490 Review.

9

Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis.

Dhib-Jalbut S, Chen M, Henschel K, Ford D, Costello K, Panitch H. Dhib-Jalbut S, et al. Among authors: panitch h. Mult Scler. 2002 Dec;8(6):485-91. doi: 10.1191/1352458502ms862oa. Mult Scler. 2002. PMID: 12474988 Clinical Trial.

10

Gamma-interferon induction in patients with chronic progressive MS.

Bever CT Jr, Panitch HS, Levy HB, McFarlin DE, Johnson KP. Bever CT Jr, et al. Among authors: panitch hs. Neurology. 1991 Jul;41(7):1124-7. doi: 10.1212/wnl.41.7.1124. Neurology. 1991. PMID: 1829795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters